Literature DB >> 10024542

Role of antibodies against Bordetella pertussis virulence factors in adherence of Bordetella pertussis and Bordetella parapertussis to human bronchial epithelial cells.

B M van den Berg1, H Beekhuizen, F R Mooi, R van Furth.   

Abstract

Immunization with whole-cell pertussis vaccines (WCV) containing heat-killed Bordetella pertussis cells and with acellular vaccines containing genetically or chemically detoxified pertussis toxin (PT) in combination with filamentous hemagglutinin (FHA), pertactin (Prn), or fimbriae confers protection in humans and animals against B. pertussis infection. In an earlier study we demonstrated that FHA is involved in the adherence of these bacteria to human bronchial epithelial cells. In the present study we investigated whether mouse antibodies directed against B. pertussis FHA, PTg, Prn, and fimbriae, or against two other surface molecules, lipopolysaccharide (LPS) and the 40-kDa outer membrane porin protein (OMP), that are not involved in bacterial adherence, were able to block adherence of B. pertussis and B. parapertussis to human bronchial epithelial cells. All antibodies studied inhibited the adherence of B. pertussis to these epithelial cells and were equally effective in this respect. Only antibodies against LPS and 40-kDa OMP affected the adherence of B. parapertussis to epithelial cells. We conclude that antibodies which recognize surface structures on B. pertussis or on B. parapertussis can inhibit adherence of the bacteria to bronchial epithelial cells, irrespective whether these structures play a role in adherence of the bacteria to these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024542      PMCID: PMC96428     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.

Authors:  K Morokuma; A Ginnaga; T Nishihara; S Tsunoda; M Furukawa; K Aihara; M Sakoh
Journal:  Dev Biol Stand       Date:  1991

2.  Description of a hybridoma bank towards Bordetella pertussis toxin and surface antigens.

Authors:  J T Poolman; B Kuipers; M L Vogel; H J Hamstra; J Nagel
Journal:  Microb Pathog       Date:  1990-06       Impact factor: 3.738

3.  Epidemics of parapertussis. 20 years' observations in Denmark.

Authors:  H Lautrop
Journal:  Lancet       Date:  1971-06-12       Impact factor: 79.321

4.  Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.

Authors:  J W Petersen; P Andersen; P H Ibsen; C Capiau; C H Wachmann; K Hasløv; I Heron
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

5.  Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; M H Witvliet; C R Manclark
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis.

Authors:  U Heininger; K Stehr; S Schmitt-Grohé; C Lorenz; R Rost; P D Christenson; M Uberall; J D Cherry
Journal:  Pediatr Infect Dis J       Date:  1994-04       Impact factor: 2.129

7.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Authors:  N Khelef; B Danve; M J Quentin-Millet; N Guiso
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent.

Authors:  D A Blumberg; E Pineda; J D Cherry; A Caruso; J V Scott
Journal:  Am J Dis Child       Date:  1992-10

10.  Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation.

Authors:  R Willems; A Paul; H G van der Heide; A R ter Avest; F R Mooi
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

View more
  8 in total

1.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

Review 2.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

3.  Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis.

Authors:  W G Hu; J Chen; J C McMichael; X X Gu
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.

Authors:  Xuqing Zhang; Maria Eugenia Rodríguez; Eric T Harvill
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

5.  Immunoproteomic analysis of human serological antibody responses to vaccination with whole-cell pertussis vaccine (WCV).

Authors:  Yong-Zhang Zhu; Cheng-Song Cai; Wei Zhang; Hong-Xiong Guo; Jin-Ping Zhang; Ya-Yong Ji; Guang-Yuan Ma; Jia-Lin Wu; Qing-Tian Li; Cheng-Ping Lu; Xiao-Kui Guo
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

6.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.

Authors:  Nao Otsuka; Hyun-Ja Han; Hiromi Toyoizumi-Ajisaka; Yukitsugu Nakamura; Yoshichika Arakawa; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

7.  A gel-free proteomic-based method for the characterization of Bordetella pertussis clinical isolates.

Authors:  Yulanda M Williamson; Hercules Moura; Kaneatra Simmons; Jennifer Whitmon; Nikkol Melnick; Jon Rees; Adrian Woolfitt; David M Schieltz; Maria L Tondella; Edwin Ades; Jacquelyn Sampson; George Carlone; John R Barr
Journal:  J Microbiol Methods       Date:  2012-04-18       Impact factor: 2.363

8.  Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection.

Authors:  Youyi Zhang; Zihan Ran; Miaomiao Tian; Yang Zhou; Jingcheng Yang; Juan Yin; Daru Lu; Rui Li; Jiang Zhong
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.